Pills and needles: factors affecting treatment choice in colorectal cancer.
Project Member(s): De Abreu Lourenco, R.
Start year: 2013
Summary: Why are some patients with metastatic colorectal cancer (CRC) treated with an oral drug (capecitabine) while others receive an intravenous drug (5-FU)? While these two drugs have similar outcomes, they differ in terms of their side effects and the resources required for their administration. Using information from the Prince of Wales (POW) hospital database and supporting records, this study will explore the patient, disease and treatment characteristics that are associated with the choice of drug. Data will be analysed descriptively and quantitatively using logistic regression. The results of the study will increase our understanding of what drives differences in treatment between patients and whether this leads to different outcomes.
Keywords: treatment administration, oral, intravenous, cancer, determinants
FOR Codes: Health Economics, Health Policy Economic Outcomes, Health economics , Health policy evaluation, Evaluation of health and support services not elsewhere classified